×ðÁú¿­Ê±

EN
EN
  • ÓªÒµ×Éѯ

    Öйú£º

    Email: marketing@medicilon.com.cn

    ÓªÒµ×ÉѯרÏߣº400-780-8018

    £¨½öÏÞЧÀÍ×Éѯ £¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©

    ´¨É³×ܲ¿µç»°: +86 (21) 5859-1500

    ÍâÑó£º

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

ÔÚÏßÁôÑÔ¡Á
µã»÷Çл»
News information
ÐÂÎÅ×ÊѶ

ÔçÆÚDMPKÑо¿ÐèÒª¾ÙÐÐÄÄЩÊÔÑé

2021-08-20
|
»á¼ûÁ¿£º

¹ØÓÚС·Ö×Ó»¯ºÏÎïÀ´Ëµ £¬×î³£¼ûµÄ¾ÍÊÇÌåÍâ´úлÎȹÌÐÔµÄÑо¿ £¬°üÀ¨¸Î΢Á£Ìå¡¢S9¡¢¸Îϸ°û¡¢Ñª½¬¡¢È«ÑªÖеĴúлÎȹÌÐÔ¡£
ÌåÍâ´úлÎȹÌÐÔÑо¿

¸Î΢Á£Ìå
ÌåÍâ´úлÎȹÌÐÔÑо¿

S9
ÌåÍâ´úлÎȹÌÐÔÑо¿

¸Îϸ°û
ÌåÍâ´úлÎȹÌÐÔÑо¿

Ѫ½¬
ÌåÍâ´úлÎȹÌÐÔÑо¿

ȫѪ

¸úÂþÑÜÓйصÄÒ»·½ÃæÊÇѪ½¬ÂѰ×Á¬Ïµ £¬ÉÐÓÐÄÔ×éÖ¯¡¢Î¢Á£ÌåÂÑ°× £¬FBSµÄÂѰ×Á¬Ïµ £¬ºÍȫѪѪ½¬·ÖÅɱÈ¡£

ÔÚÉøÍ¸ÐÔºÍתÔË·½ÃæÖ÷ÒªÊÇCaco-2Ä£×ÓÒÔ¼°ÖÖÖÖתÔËÌåÑо¿ £¬°üÀ¨P-gp¸úBCRP £¬ÕâÁ½¸öÊÇÖ÷ÒªµÄÍâÅÅתÔËÌå¡£

ÉÐÓÐÏÖÔÚÔ½À´Ô½Êܵ½ÖØÊÓµÄһЩUNTAKE¾ÍÊÇÉãÈ¡µÄתÔËÌå £¬ÔÚÌåÍâ´úлøµÄÒ©ÎïÏ໥×÷ÓÃDDIÑо¿ÄÚÀïÖ÷ÒªÊÇP450øÒÖÖÆ¡£È»ºóÉÐÓÐʱ¼äÒÀÀµÐÔÒÖÖÆ¡¢ P450ÓÕµ¼ £¬´úлø±íÐÍ´úл²úÆ·ÅжÏÑо¿¡£

ÌåÄÚPK·½ÃæÀàÐ;͸ü¶àÁË £¬Æ¾Ö¤ÐèÇóÎÒÃÇ¿ÉÒÔÑ¡Ôñ²î±ð¾Þϸ¶¯ÎïÖÖÊô £¬²î±ð¸øÒ©·½·¨¸øÒ©Í¾¾¶ £¬²ÉѪսÂԵȵÈ¡£

³ýÁËѪ½¬PKÒÔÍâ £¬¹ØÓÚÖÐÊàÉñ¾­ÏµÍ³£¨CNS£©Ò©ÎïÀ´Ëµ,ÎÒÃÇÐèÒª¿ªÕ¹ÑªÄÔÆÁÕÏͨ͸ÐÔ£¨BBB£©µÄÌåÄÚÑо¿ £¬ÊÕÂÞÄÔ×éÖ¯ºÍCSF £¬²â¶¨ÄÔ×éÖ¯ºÍCSFÖеÄÒ©ÎïŨ¶È¡£Í¬Ê±Á¬ÏµÂѰ×Á¬ÏµÊµÑéÈ¥ÆÀ¼ÛѪÄÔÆÁÕ϶ÔÒ©ÎïÔËÊäµÄ×è°­ £¬¸ü׼ȷµÄÖ¸µ¼CNSÒ©ÎïµÄ¿ª·¢¡£

ÁíÍâÈç×éÖ¯ÂþÑÜ¡¢ÉøÍ¸ÊµÑéÉÐÓÐÒ©ÎïÏ໥×÷ÓÃDDI £¬Ò²ÊÇ¿ÉÒÔÆ¾Ö¤ÐèÒªÀ´°ÑËü¾öÒé·ÅÔÚÔçÆÚ»òÕß˵ÊÇÉÔºó½×¶Î¿ªÕ¹¡£

Ïà¹ØÐÂÎÅ
×ðÁú¿­Ê±µÄÒ©ÎïתÔËÌåÑо¿
2016-08-11
Ò©ÎïתÔËÌåµÄÑо¿×÷Ϊ×ðÁú¿­Ê±Ï¸»¯Ð§ÀÍϵͳÖеÄÒ»Ïî³ÉÊìÊÖÒÕ¿ÉÒÔΪÐÂÒ©Éè¼Æ¡¢Ìá¸ßÒ©Îï°ÐÏòÐÔ¼°Ò©ÎïÏ໥×÷ÓõÈÑо¿Ìṩ¿É¿¿ÒÀ¾Ý¡£
·¢Ã÷ÓÃÓÚ¾Ö²¿ÖÎÁÆÅ£Æ¤Ñ¢µÄÐÂÐÍPDE4ÒÖÖÆ¼Á £¬Ð¡Êó¡¢´óÊóºÍÈ˸Î΢Á£ÌåµÄ´úлÎȹÌÐÔʵÑéͨ¹ý×ðÁú¿­Ê±²â¶¨
2023-06-28
Psoriasis is a common immune-mediated skin disorder manifesting in abnormal skin plaques, and PDE4 is an effective target for the treatment of inflammatory diseases such as psoriasis.
ARD-2585ÊÇÒ»ÖÖ¿Ú·þÓÐÓõÄPROTACÐÛ¼¤ËØÊÜÌå½µ½â¼Á £¬¿ÉÓÃÓÚÖÎÁÆÍíÆÚǰÏßÏÙ°©¡£¸Î΢Á£ÌåÎȹÌÐԲⶨ¡¢Ñª½¬ÎȹÌÐԲⶨºÍhERG²â¶¨Í¨¹ý×ðÁú¿­Ê±¾ÙÐÐ
2023-07-05
A PROTAC-based androgen receptor (AR) degrader is a bifunctional small molecule, consisting of an AR ligand that binds to AR protein, and a ligand that binds to and recruits an E3 ligase complex, tethered together through a linker. Researchers report the discovery of exceptionally potent and orally bioavailable PROTAC AR degrader ARD-2585 (Compound 43). ARD-2585 is a promising AR degrader for extensive investigations for the treatment of advanced prostate cancer. The liver microsomal stability assay was performed by Medicilon. The plasma stability assay was performed by Medicilon. The hERG assay was performed by Medicilon.
¡Á
ËÑË÷ÑéÖ¤
µã»÷Çл»
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿